PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 51 filers reported holding PSYCHEMEDICS CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $16,000 | -42.9% | 1,694 | -45.2% | 0.00% | 0.0% |
| Q3 2019 | $28,000 | -48.1% | 3,094 | -42.6% | 0.00% | -66.7% |
| Q2 2019 | $54,000 | +1.9% | 5,391 | +42.8% | 0.00% | 0.0% |
| Q1 2019 | $53,000 | +65.6% | 3,774 | +86.5% | 0.00% | +50.0% |
| Q4 2018 | $32,000 | +52.4% | 2,024 | +80.6% | 0.00% | +100.0% |
| Q3 2018 | $21,000 | -25.0% | 1,121 | -22.9% | 0.00% | -50.0% |
| Q2 2018 | $28,000 | -37.8% | 1,454 | -30.9% | 0.00% | -33.3% |
| Q1 2018 | $45,000 | -46.4% | 2,104 | -48.7% | 0.00% | -57.1% |
| Q4 2017 | $84,000 | +6.3% | 4,104 | -4.0% | 0.01% | 0.0% |
| Q3 2017 | $79,000 | -12.2% | 4,276 | +18.6% | 0.01% | -22.2% |
| Q2 2017 | $90,000 | +18.4% | 3,604 | -5.3% | 0.01% | +28.6% |
| Q1 2017 | $76,000 | +111.1% | 3,804 | +158.1% | 0.01% | +75.0% |
| Q4 2016 | $36,000 | +260.0% | 1,474 | +194.8% | 0.00% | +300.0% |
| Q3 2016 | $10,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 250,388 | $3,974,000 | 4.46% |
| QUANTUM CAPITAL MANAGEMENT | 63,246 | $1,004,000 | 0.58% |
| Mill Road Capital Management LLC | 14,896 | $236,000 | 0.30% |
| Gs Investments, Inc. | 15,800 | $250,746,000 | 0.21% |
| RBF Capital, LLC | 87,917 | $1,395,000 | 0.18% |
| North Star Investment Management Corp. | 85,282 | $1,353,000 | 0.18% |
| CRAWFORD INVESTMENT COUNSEL INC | 297,675 | $4,724,000 | 0.16% |
| Uniplan Investment Counsel, Inc. | 145,677 | $2,311,000 | 0.16% |
| DEPRINCE RACE & ZOLLO INC | 282,186 | $4,478,000 | 0.13% |
| Moors & Cabot, Inc. | 37,932 | $605,000 | 0.10% |